|
Sanofi backed its full-year earnings guidance after it reported first-quarter profit ahead of consensus, with sales growth driven by continued strength in anti-inflammatory drug Dupixent and its new drug launches.
|
|
Ford Q1 earnings beat, rosy 2024 outlook, cost discipline welcome news CNBCFord tops Q1 earnings expectations, sees full-year profit 'tracking to high-end' of guidance Yahoo FinanceFord Q1 profits fall as Ford Blue hit from F-150 ramp-up Detroit NewsFord just reported a massive loss on every electric vehicle it sold CNNFord stock rises as EV losses are held in check and hybrid sales surge MarketWatch
|
|